Aarti Drugs Limited (AARTIDRUGS) Share Analysis
NSE · Healthcare · Pharmaceuticals
Aarti Drugs Limited (NSE: AARTIDRUGS) is an Indian listed company in the Pharmaceuticals sector and a constituent of NIFTY Microcap 250. As of 21 Sep 2026, the share price was ₹432.00, market capitalisation ₹3,941 Cr, P/E 20.4, ROE 13.4%.
Get the AI verdict on AARTIDRUGS: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
Stored fundamentals as of 21 Sep 2026 — not a live quote. Signed-in analysis uses same-day data.
AARTIDRUGS price and valuation
- Share price
- ₹432.00
- Market cap
- ₹3,941 Cr
- P/E ratio
- 20.4
- P/B ratio
- 2.54
- EPS
- ₹20.95
- Book value per share
- ₹170.00
- Dividend yield
- 0.46%
AARTIDRUGS profitability and growth
- ROE
- 13.4%
- ROCE
- 12%
- Debt to equity
- 0.37
- Revenue growth (3 yr)
- -2%
- Revenue growth (5 yr)
- 4%
- Profit growth (3 yr)
- 5%
- Profit growth (5 yr)
- -7%
AARTIDRUGS 52-week range
- 52-week high
- ₹534.00
- 52-week low
- ₹318.95
- Face value
- ₹10.00
AARTIDRUGS shareholding pattern
- Promoters
- 54.43%
- FIIs
- 1.52%
- DIIs
- 10.29%
- Public
- 33.76%
Index membership: NIFTY Microcap 250.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.